Literature DB >> 10450733

Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.

D F Roses1, A D Brooks, M N Harris, R L Shapiro, J Mitnick.   

Abstract

OBJECTIVE: To assess the complications of level I and II axillary lymph node dissection in the treatment of stage I and II breast cancer, with breast-conservation surgery and mastectomy. SUMMARY BACKGROUND DATA: The role of axillary dissection for staging, and as an effective means of controlling regional nodal disease, has long been recognized. As small and low-grade lesions have been detected more frequently, and as its therapeutic impact has been questioned, axillary dissection has increasingly been perceived as associated with significant complications.
METHODS: Two hundred patients, 112 of whom had breast-conservation surgery with axillary dissection and 88 of whom had total mastectomy with axillary dissection, were evaluated 1 year or more after surgery for arm swelling as well as nonedema complications. All patients had arm circumference measurements at the same four sites on both the operated and nonoperated sides.
RESULTS: No patient had an axillary recurrence. The mean difference in circumference on the nonoperated versus operated side was 0.425 cm +/- 1.39 at the midbiceps (p < 0.001), 0.315 cm +/- 1.27 at the antecubital fossa (p < 0.001), 0.355 cm +/- 1.53 at the midforearm (p < 0.005), and 0.055 cm +/- 0.75 at the wrist (n.s.). Seven patients (3.5%) had mild swelling of the hand. Heavy and obese body habitus were the only significant predictors of edema on multivariate analysis. One hundred fifty-three (76.5%) patients had numbness or paresthesias of the medial arm and/or axilla after surgery; in 125 (82%) of these, the problem had lessened or had resolved on follow-up assessment.
CONCLUSIONS: The characterization of a level I and II axillary dissection as a procedure with significant complications does not appear justified based on this experience.

Entities:  

Mesh:

Year:  1999        PMID: 10450733      PMCID: PMC1420861          DOI: 10.1097/00000658-199908000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  46 in total

1.  Radical axillary dissection in the staging and treatment of breast cancer.

Authors:  A B Ball; R Waters; S Fish; J M Thomas
Journal:  Ann R Coll Surg Engl       Date:  1992-03       Impact factor: 1.891

2.  Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer.

Authors:  N Baxter; D McCready; J A Chapman; E Fish; H Kahn; W Hanna; M Trudeau; H L Lickley
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

3.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

4.  Axillary lymph node dissection for melanoma.

Authors:  M N Harris; S L Gumport; H Maiwandi
Journal:  Surg Gynecol Obstet       Date:  1972-12

5.  Preservation of the intercostobrachial nerve during axillary dissection for carcinoma of the breast.

Authors:  I Teicher; B Poulard; L Wise
Journal:  Surg Gynecol Obstet       Date:  1982-12

6.  Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

Authors:  M J Silverstein; E D Gierson; J R Waisman; G M Senofsky; W J Colburn; P Gamagami
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.

Authors:  J Pigott; R Nichols; W A Maddox; C M Balch
Journal:  Surg Gynecol Obstet       Date:  1984-03

8.  Risk of lymphoedema following the treatment of breast cancer.

Authors:  M W Kissin; G Querci della Rovere; D Easton; G Westbury
Journal:  Br J Surg       Date:  1986-07       Impact factor: 6.939

9.  Distribution of axillary node metastases by level of invasion. An analysis of 539 cases.

Authors:  U Veronesi; F Rilke; A Luini; V Sacchini; V Galimberti; T Campa; E Dei Bei; M Greco; A Magni; M Merson
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

10.  Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.

Authors:  P P Rosen; M L Lesser; D W Kinne; E J Beattie
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

View more
  30 in total

1.  Design of an injectable synthetic and biodegradable surgical biomaterial.

Authors:  Peter N Zawaneh; Sunil P Singh; Robert F Padera; Peter W Henderson; Jason A Spector; David Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysis.

Authors:  Tiphaine Raia-Barjat; Béatrice Trombert; Abir Khaddage; Catherine Douchet; Pierre Seffert; Michel Peoc'h; Alexander Tuan Falk; Nicolas Magné; Céline Chauleur
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

3.  Cost-effectiveness of positron emission tomography in breast cancer.

Authors:  J Scott Sloka; Peter D Hollett; Maria Mathews
Journal:  Mol Imaging Biol       Date:  2005 Sep-Oct       Impact factor: 3.488

Review 4.  Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.

Authors:  Aoife Maguire; Edi Brogi
Journal:  Arch Pathol Lab Med       Date:  2016-08       Impact factor: 5.534

5.  Effects of Fibrin Sealant on Seroma Reduction for Patients with Breast Cancer Undergoing Axillary Dissection: Meta-Analysis of Randomized Controlled Trials.

Authors:  Ya-Ting Chang; Shen-Liang Shih; El-Wui Loh; Ka-Wai Tam
Journal:  Ann Surg Oncol       Date:  2020-06-20       Impact factor: 5.344

6.  Lymphatic complications in surgery: possibility of prevention and therapeutic options.

Authors:  Francesco Boccardo; Corrado Cesare Campisi; Lidia Molinari; Sara Dessalvi; Pier Luigi Santi; Corradino Campisi
Journal:  Updates Surg       Date:  2012-07-21

7.  Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.

Authors:  Igor Langer; Ulrich Guller; Gilles Berclaz; Ossi R Koechli; Gabriel Schaer; Mathias K Fehr; Thomas Hess; Daniel Oertli; Lucio Bronz; Beate Schnarwyler; Edward Wight; Urs Uehlinger; Eduard Infanger; Daniel Burger; Markus Zuber
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

8.  Potential risk factors for the development of seroma following mastectomy with axillary dissection.

Authors:  Xiao-Feng Pan; Jin-Liang Huan; Xian-Ju Qin
Journal:  Mol Clin Oncol       Date:  2014-09-25

Review 9.  Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials.

Authors:  Xiao-Dong He; Zhi-Hui Guo; Jin-Hui Tian; Ke-Hu Yang; Xiao-Dong Xie
Journal:  Med Oncol       Date:  2010-09-09       Impact factor: 3.064

10.  Reassessing the role of axillary lymph-node dissection in patients with early-stage breast cancer.

Authors:  Jeff Marschall; Patrik Nechala; Patrick Colquhoun; Rajni Chibbar
Journal:  Can J Surg       Date:  2003-08       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.